Label (71610 0878 60)
Doxazosin Tablet
Product Images NDC 71610-878
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Doxazosin (NDC 71610-878). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Aphena (Aphena)
Doxazosin-structure.jpg (Doxazosin Structure)
Figure1.jpg (Figure1)
The provided text seems to be a comparison table related to the mean change in total symptom score and the mean increase in maximum urinary flow rate from baseline. It also includes information on the duration of treatment in weeks. The results appear to show comparisons of treatment effects with placebo and baseline, with a note about doxazosin titration to a maximum of 8 mg. It seems to be a clinical study or trial evaluating the effectiveness of a treatment on symptoms and urinary flow rate in a certain timeframe.*
Table3.jpg (Table3)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
